公司资料
ClearPoint Neuro 股价、新闻与催化剂
- 股票代码:
- CLPT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
15.50 USD (+1.04%)
收盘价
最后更新: 2026年8月17日
371M USD
市值
股价为何变动
As of Aug 17, 2026, CLPT closed up 1.04% at $15.50. No new same-company headline was identified in the current news window.
公司概览
Brain and Spine Navigation Company
ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine.
ClearPoint Navigation
The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics.
Cell and Gene Therapy Enablement
ClearPoint works with biopharmaceutical partners on preclinical and clinical delivery of cell and gene therapies directly into the central nervous system.
Neurocritical Care Expansion
The acquisition of IRRAS added the IRRAflow active fluid-exchange system, extending the portfolio into management of intracranial bleeding and neurocritical care.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。